Quantcast
Last updated on April 18, 2014 at 16:41 EDT

Latest Smith, Kline & French Stories

2011-02-09 07:00:00

PITTSBURGH, Feb. 9, 2011 /PRNewswire/ -- GlaxoSmithKline Consumer Healthcare North America, the maker of Aquafresh® is pleased to announce that Aquafresh® iso-active® Whitening was voted Product of the Year USA in the toothpaste category. In a survey of more than 60,000 American shoppers (22,939 in the toothpaste category) conducted by global research firm TNS, Aquafresh iso-active toothpaste was one of 22 products selected for...

2011-02-07 06:56:00

LONDON, February 7, 2011 /PRNewswire/ -- GlaxoSmithKline (GSK) today announces that it has received a licence extension for alli, the first pharmacy-only weight loss aid licensed for use throughout Europe. This license extension is for new chewable tablets. The new alli tablets are planned to be on sale in pharmacies throughout the UK in April this year. alli is for overweight adults with a BMI of 28 or more and can help boost your weight loss compared with dieting alone. alli should...

2011-01-21 06:00:00

MISSISSAUGA, Ontario, Jan. 21, 2011 /PRNewswire/ -- GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion, recommending marketing authorisation for Trobalt(TM) (retigabine) as an adjunctive (add-on) treatment of partial onset seizures (a form of epilepsy where a seizure begins in a specific area in one side of the...

2010-12-01 17:26:00

PHILADELPHIA, Dec. 1, 2010 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for Avodart® (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum...

2010-12-01 15:15:00

LONDON, RESEARCH TRIANGLE PARK, N.C., and MISSISSAUGA, Ontario, Dec. 1 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International, Inc. (NYSE: VRX; TSX) announced receipt of a Complete Response letter from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) for ezogabine, an investigational anti-epileptic drug being studied for the adjunctive treatment of adults with partial-onset seizures. A Complete Response letter is...

2010-11-08 14:30:00

DURHAM, N.C., Nov. 8, 2010 /PRNewswire/ -- GlaxoSmithKline, one of the world's leading research-based pharmaceutical and healthcare companies, today announced the 12 winners of its GlaxoSmithKline IMPACT Awards. The North Carolina and Philadelphia-area healthcare nonprofit organizations received $480,000 in grant funding for providing access to healthcare for the underserved in their communities. "All of the GlaxoSmithKline IMPACT Award winners are leaders in the nonprofit world and in...

2010-10-28 08:00:00

YORK, Pa., Oct. 28 /PRNewswire/ -- GlaxoSmithKline (NYSE: GSK) Consumer Healthcare is taking its commitment to renewable energy to the next level. Today, GSK begins installing North America's largest rooftop solar array at its Northeast Regional Distribution Center (RDC) in York, Pa. GSK's sustainability initiatives were just recognized in Newsweek's "2010 Green Ranking" as ranking fifth among the greenest companies in the world. (Photo:...

2010-09-24 14:41:00

PHILADELPHIA Sept. 24 /PRNewswire-FirstCall/ -- CDI Corp. (NYSE: CDI), a leading provider of engineering and information technology outsourcing solutions and professional staffing, has announced that Anna M. Seal has been elected to its Board of Directors and will serve on the Board's Audit Committee. Ms. Seal is Senior Vice President and Chief Financial Officer of GlaxoSmithKline's (GSK) Global Manufacturing and Supply Division. She previously served as Senior Vice President and CFO of...

2010-07-22 11:26:00

WASHINGTON, July 22 /PRNewswire-USNewswire/ -- National Pharmaceutical Council (NPC) President Dan Leonard today welcomed GlaxoSmithKline (GSK) as the latest member of the health policy research organization. "NPC is focused on bringing together thought leaders and supporting the research to inform important health policy discussions related to the generation and use of comparative evidence. This role is particularly critical given the creation of the Patient-Centered Outcomes Research...

2010-06-02 17:05:00

RESEARCH TRIANGLE PARK, N.C., June 2 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced that it has received a letter from the U.S. Food and Drug Administration directing revisions to product labeling for its respiratory products Serevent® and Advair®. The letter concludes discussions between GSK and the agency following FDA advisory committee meetings regarding the safety profile of long-acting beta2-agonists in the treatment of...